Prostaglandins in the gut and their relationship to non-steroidal anti-inflammatory drugs

Bailliere's Clinical Rheumatology

Volumn 3, Issue 2, 1989, Pages 247-269

  Semble, Elliott L ^a   Wu, Wallace C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZAPROPAZONE; CYCLIC AMP; FENCLOFENAC; FLUFENAMIC ACID; FLURBIPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2;

ADULT; AGED; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; HUMAN; ILEUM; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STOMACH INJURY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMAN; INTESTINAL MUCOSA; PROSTAGLANDINS;

EID: 0024420004     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(89)80020-2     Document Type: Article

References (156)

1. Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection
2. Gastric acid inhibition by antral acidification mediated by endogenous prostaglandins
3. 2 in the human stomach, and a study of its effects on human isolated gastric muscle
4. 2 and gastric acid secretion in man
5. Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis
6. 2, and carbenoxolone
7. Effect of non-steroidal antiinflammatory drugs and prostaglandins on the permeability of the human small intestine
8. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans
9. Blood and protein loss via small intestinal inflammation induced by non-steroidal antiinflammatory drugs
10. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures
11. Effect of repeated administration on the gastric mucosal barrier and cell turnover
12. 2
13. 2 and metiamide on established canine gastric mucosal barrier damage
14. Indomethacin-induced intestinal lesions in the rat
15. 2α concentrations on ion transport across human jejunal mucosa
16. Gastroscopic evaluation of antiinflammatory agents
17. Differential effects of prostaglandins in the mesenteric vascular bed
18. Prostaglandin cytoprotection of gastric mucosa
19. Prevention by mild irritants of gastric necrosis produced by rats by sodium taurocholate
20. 2 on aspirin-induced disruption of gastric permeability barrier in dogs
21. 1 on the pentagastrin-stimulated gastric secretion in man
22. Evidence for cytoprotection by endogenous prostaglandins in gastric mucosa treated with bile acid
23. 2 prevents gastric mucosal damage
24. 2 prevents aspirin and indomethacin damage to human gastric mucosa
25. 2
26. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study
27. Aspirin-induced human antral injury is reduced by vodka pretreatment
28. Non-steroidal antiinflammatory drugs and peptic ulcer perforation
29. 1 derivative, SC-29333 and aspirin on gastric ionic fluxes and potential differences in dogs
30. Acute perforation of colonic diverticula associated with short-term indomethacin
31. Gastric mucosal injury by fatty and acetylsalicylic acids
32. Ethanol damage to canine oxyntic glandular mucosa
33. Salicylate damage to the gastric mucosal barrier
34. 1 to enhance the angiographic visualization of the splanchnic circulation
35. Intestinal perforation associated with osmotic slow release indomethacin capsules
36. Ulcer of the cecum during oxyphenylbutazone (Tanderil) therapy
37. Effects of fasting, stress and drugs on gastric glycoprotein synthesis in the rat
38. Prostaglandin-stimulated gastric mucus secretion in man
39. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog
40. Effect of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum, and duodenum
41. 2 reduces chenodeoxycholate-induced small intestinal mucosal injury in the rat
42. Zur Kenntnis der pharmakologischen Wirkungen von Nativsekreten und Extrakten männlicher accessorischer Geschlechtsdrüsen
43. Indomethacin-induced intestinal inflammation
44. 2
45. In vivo suppression of prostaglandin biosynthesis by non-steroidal antiinflammatory agents
46. The effects of acetic and acetylsalicylic acids on the appearance of gastric mucosal surface epithelium in the scanning electron microscope
47. 2-methyl ester on the gastric mucosa in patients with peptic ulceration: an endoscopic and histologic study
48. Effect of acetylsalicylate on alkalinization, acid secretion, and electrogenic properties in the isolated gastric mucosa
49. 2α: a proposed explanation for some of the cytoprotective actions of prostaglandins
50. Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretion in the amphibian isolated gastric mucosa
51. Prostaglandins alter the relationship between gastric hydrogen ion concentration and flow: evidence for the stimulation of non-parietal secretion in the cat
52. 2, and endoscopic study
53. A depressor substance in seminal fluid
54. Gastric adaptation occurs with aspirin administration in man
55. Fecal blood loss by oral and intravenous administration of various salicylates
56. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?
57. Evidence that adaptive cytoprotection in rats is not
58. Duodenal mucosa synthesis of prostaglandins in duodenal ulcer disease
59. 1 on gastric secretion and GI motility in man
60. 2 on gastric mucosal bleeding caused by aspirin
61. 1 analogue on aspirin-induced gastric bleeding and secretion
62. The effect of salicylates upon the stomach of dogs
63. Cell shedding by the stomach and duodenum
64. Acute effect of systemic aspirin on gastric mucosa in man
65. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal antiinflammatory drug therapy?
66. 2 prostaglandins of human gastric mucus output
67. 2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases
68. Small intestinal ulcers and intestinal flora in rats given indomethacin
69. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol
70. Role of prostaglandins in the formation of aspirin-induced gastric ulcers
71. Role of locally generated prostaglandins in adaptive gastric cytoprotection
72. Mechanism of action of aspirin on canine gastric mucosa
73. Effects of cyclic AMP, ouabain and furosemide on ion transport in isolated canine mucosa
74. Adaptation of gastric mucosa to repeated indomethacin administration
75. 2β stimulate rat gastric mucin release
76. 2
77. Use of antiinflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage
78. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers
79. 1 methyl ester (SC-29333) versus aspirin-shock gastric ulcerogenesis in the dog
80. Gastrointestinal blood loss from aspirin and sodium salicylate tablets in man
81. Effects of salicylates on the canine stomach: a morphological and histochemical study
82. Effect of indomethacin on basal and histamine stimulated gastric acid secretion
83. 2 histamine interactions on cAMP, cGMP and acid production in isolated fundic glands
84. Role of surface-active phospholipids in gastric cytoprotection
85. 2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa
86. Endogenous gastric mucosal prostaglandins: their role in mucosal integrity
87. The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy
88. Small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs for rheumatoid arthritis
89. 2 on rat gastrointestinal function
90. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal antiinflammatory drugs
91. Steatorrhoea complicating therapy with mefenamic acid
92. 2
93. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms
94. Mechanisms of mucosal recovery from acute gastric damage: roles of extracellular mucus and cell migration
95. 2
96. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants
97. Recurrent small bowel obstruction associated with phenylbutazone
98. 2α on human gastric function
99. Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration
100. On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs
101. Prostaglandins and prostaglandin metabolites in human gastric juice
102. Release of prostaglandins by small intestinal tissue of man and rat in vitro and the effect of endotoxin in the rat in vivo
103. Experimental analysis of hydrogen ion diffusion in gastrointestinal mucus glycoprotein
104. Enteritis and colitis associated with mefenamic acid
105. The effects of aspirin and other nonsteroidal antiinflammatory analgesic drugs on gastrointestinal mucus glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions
106. Relationship of gastric mucosal damage induced by pigs by antiinflammatory drugs to their effects on prostaglandin production
107. 2 release in vitro
108. Relapse of ulcerative proctocolitis during treatment with nonsteroidal antiinflammatory drugs
109. 2 into gastric juice during stimulation of muscarinic-and gastric receptors in dogs and in humans
110. Colitis caused by non-steroidal antiinflammatory drugs
111. Mechanisms of gastric mucosal protection: a role for the ‘mucus-bicarbonate’ barrier
112. A demonstration of bicarbonate production by the normal human stomach in vivo
113. 2
114. Effects of prostaglandins on the stomach and the intestine
115. An intestinal disease produced experimentally by a prostaglandin deficiency
116. Antisecretory, antiulcer, cytoprotective and diarrheaogenic properties of prostaglandins
117. Resistance to germ-free rats to indomethacin-induced intestinal lesions
118. Inhibition of gastric secretion by prostaglandin
119. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol HCl, NaOH, hypertonic NaCl and thermal injury
120. Mild irritants present gastric necrosis through adaptive cytoprotection mediated by prostaglandins
121. Ibuprofen (Brufen) in cholera and other diarrhoeal disorders
122. Adaptation of the gastric mucosa to repeated administration of aspirin in the rat
123. Role of food in gastrointestinal ulceration produced by indomethacin in the rat
124. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics
125. Ileal stricturing after long-term indomethacin treatment
126. Prostaglandin cytoprotection against ethanol-induced gastric injury in the rat: a histologic and cytologic study
127. Lower gastrointestinal side effects of nonsteroidal antiinflammatory drugs
128. Effects of calcium depletion on the junctional complex between oxyntic cells of gastric glands
129. 2 output in human subjects
130. Drug-induced ulceration and perforation of the small intestine
131. Incidence of gastric lesions in patients with rheumatic diseases on chronic aspirin therapy
132. Prostaglandin production by intact isolated gastric parietal cells
133. 2 in the epithelial and subepithelial layers of the rat intestine
134. Jejunal ulcers produced by indomethacin
135. 2 concentrations in patients with acute cholera
136. 13 reductase content of gastrointestinal organs of rabbits and rats
137. Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy
138. 2-methyl ester on aspirin and indomethacin-induced gastric and intestinal lesions in mini pigs
139. Prostaglandin protection of ethanol induced small intestine and gastric mucosal damage in rats
140. Prostaglandin protection of the gastric mucosa against alcohol injury—a dynamic time-related process
141. 2 in irradiated rat ileum
142. Ulcerations of the colon associated with naproxen and acetylsalicylic acid treatment
143. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs
144. 2
145. Prostaglandin protection of the rat colonic mucosa from damage induced by ethanol
146. Colitis associated with non-steroidal anti-inflammatory drugs.
147. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid
148. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts, and the actions of prostaglandins
149. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat
150. 2 in gastrointestinal tissue
151. Prostanoids as regulators of gastrointestinal function
152. Prostanoids as regulators of gastrointestinal function
153. Formation of prostacyclin by the gastric mucosa and its actions on gastric function
154. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
155. Retardation of acid diffusion by pig gastric mucosa: a potential role in mucosal protection
156. A note on indomethacin suppositories in rheumatic conditions